Sunday, November 17, 2024 1:45:35 PM
suit,
Thanks for asking 😶
Fact ✅️: In the global pharma industry, countless clinical trials are planned but never initiated, often due to various factors, especially for pre-commercial companies. It is not reasonable to draw negative conclusions from trials that were never conducted. Let’s focus on the trials that have been successfully funded and executed and those that are ongoing now, especially combo studies!
⭐️Combo is King!⭐️
Let’s look at the 2 examples of clinical trials relevant to the TWO patent-fortified novel dendritic cell technologies owned by NWBO…
Here is the combo trial that is funded by a peer-reviewed grant awarded to Roswell Park by the U.S. DoD:
https://clinicaltrials.gov/study/NCT04348747
Here is the combo trial that is funded by a continuing peer-reviewed grant awarded to UCLA by the U.S. NIH:
https://www.clinicaltrials.gov/study/NCT04201873
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175399610
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175149927
Thanks for asking 😶
Fact ✅️: In the global pharma industry, countless clinical trials are planned but never initiated, often due to various factors, especially for pre-commercial companies. It is not reasonable to draw negative conclusions from trials that were never conducted. Let’s focus on the trials that have been successfully funded and executed and those that are ongoing now, especially combo studies!
⭐️Combo is King!⭐️
Let’s look at the 2 examples of clinical trials relevant to the TWO patent-fortified novel dendritic cell technologies owned by NWBO…
Here is the combo trial that is funded by a peer-reviewed grant awarded to Roswell Park by the U.S. DoD:
https://clinicaltrials.gov/study/NCT04348747
Here is the combo trial that is funded by a continuing peer-reviewed grant awarded to UCLA by the U.S. NIH:
https://www.clinicaltrials.gov/study/NCT04201873
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175399610
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175149927
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
